FBLN5 and chronic hepatitis C virus infection: We then investigated the plasma level of FBLN5 in 67 patients with chronic hepatitis C. Depending on the fibrosis stage, plasma FBLN5 levels increased with disease progression (P < .001, Figure 5A), whereas plasma FBLN5 levels did not increase in association with activity grade (data not shown).